Mepivacaina B.Braun (Mepivacaine Hydrochloride)

Mepivacaine works by reversibly blocking voltage‑gated sodium channels on nerve membranes, which stops the initiation and propagation of electrical impulses. This interruption of nerve signaling results in a temporary loss of sensation in the area where the drug is administered.

The appropriate dose of Mepivacaina B.Braun is determined by the prescribing clinician based on the type of procedure, the site of administration, patient weight, and overall health status. No fixed regimen is provided here; the prescriber sets the exact amount.

Safety data for mepivacaine in pregnancy and lactation are limited. Use is generally reserved for situations where the benefit to the mother outweighs potential risks to the fetus or infant, and it should be administered only under careful medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Mepivacaina B.Braun, an amide‑type anesthetic, has a slightly faster onset and longer duration than lidocaine, another common amide. It also tends to produce less vasodilation, which can reduce the need for a vasoconstrictor additive in certain procedures.

Store the product at ambient temperature, preferably below 25 °C, in its original packaging. Protect it from direct sunlight, moisture, and extreme temperature fluctuations to maintain stability and potency.

Mepivacaina B.Braun is administered by injection. It can be given epidurally, intra‑articularly, or intradermally depending on the clinical indication, using aseptic technique and appropriate needle size for the target tissue.

Serious risks include cardiac arrhythmias, seizures, methemoglobinemia, and severe allergic reactions such as anaphylaxis. These events are rare but require immediate medical attention if they occur.

Patients with known hypersensitivity to mepivacaine or other amide‑type local anesthetics, those with severe cardiac conduction disorders, and individuals with uncontrolled epilepsy should avoid using Mepivacaina B.Braun unless a specialist determines it is safe.